Dr Reddys Laboratories (RDY) Non-cash Items (2012)

Dr Reddys Laboratories (RDY) posted quarterly Non-cash Items of $7673.0 for Q2 2012.

Dr Reddys Laboratories (RDY) Non-cash Items (2012) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Non-cash Items for 1 consecutive years, with $7673.0 the latest figure, recorded in Q2 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Dr Reddys Laboratories 9.82 Bn 9.66 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2012 7,673.00
Jun 30, 2012 7,673.00